Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.63 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.63 |
| ▸ | NPC1 | O15118 | 3/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | PTGES | O14684 | 2/20 | 0.61 |
| ▸ | MMP13 | P45452 | 4/20 | 0.54 |
| ▸ | MMP2 | P08253 | 3/20 | 0.54 |
| ▸ | MMP9 | P14780 | 3/20 | 0.54 |
| ▸ | MMP8 | P22894 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | TP53 | P04637 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | GFER | P55789 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15288339 | 0.86 | MMP13 (0.71) | ATMRXFP1NPC1RAB9AGAA | |
| SCHEMBL29949328 | 0.86 | MMP13 (0.71) | ATMRXFP1NPC1RAB9AGAA | |
| SCHEMBL1170673 | 0.85 | PDPK1 (0.51) | ATMRXFP1NPC1RAB9APTGES | |
| SCHEMBL17393311 | 0.85 | NR1H4 (0.61) | ATMRXFP1NPC1RAB9AGAA | |
| SCHEMBL3337505 | 0.83 | ALDH1A1 (0.55) | ATMRXFP1NPC1RAB9AGAA | |
| SCHEMBL26753826 | 0.83 | KDM4E (0.61) | ATMRXFP1NPC1RAB9APTGES | |
| SCHEMBL27236921 | 0.83 | MMP2 (0.55) | ATMRXFP1MMP13MMP2MMP9 | |
| SCHEMBL6264476 | 0.83 | MMP2 (0.77) | RXFP1NPC1RAB9AGAAMMP13 | |
| SCHEMBL26753825 | 0.83 | MGAM (0.52) | ATMRXFP1NPC1RAB9AGAA | |
| SCHEMBL22649095 | 0.82 | NPC1 (0.67) | NPC1RAB9AGAAMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220384735-A1 | PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2022-12-01 | — | — | US | disclosed |
| US-20220384735-A1 | PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2022-12-01 | — | — | US | disclosed |
| CN-110759903-B | Novel synthesis method of thiabendazole | 南开大学 | 2022-10-28 | — | — | CN | disclosed |
| EP-4031549-A1 | PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES | Merck Patent GmbH (DE) | 2022-07-27 | — | — | EP | disclosed |
| CN-114401945-A | Peri-condensed heterocyclic compounds as materials for electronic devices | 默克专利有限公司 | 2022-04-26 | — | — | CN | disclosed |
| WO-2021053046-A1 | PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2021-03-25 | — | — | WO | disclosed |
| WO-2021053046-A1 | PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2021-03-25 | — | — | WO | disclosed |
| US-10236451-B2 | Compound and organic electroluminescent device comprising the same | DOOSAN CORPORATION (KR) | 2019-03-19 | — | — | US | disclosed |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | DOOSAN CORPORATION (KR) | 2015-06-18 | — | — | US | disclosed |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | DOOSAN CORPORATION (KR) | 2015-06-18 | — | — | US | disclosed |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | DOOSAN CORPORATION (KR) | 2015-06-18 | — | — | US | disclosed |
| WO-2014010810-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | 주식회사 두산 (KR) | 2014-01-16 | — | — | WO | disclosed |
| US-8198307-B2 | Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2012-06-12 | — | — | US | disclosed |
| US-20100145054-A1 | IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2010-06-10 | — | — | US | disclosed |
| EP-2178563-A2 | COMBINATION ANTI-CANCER THERAPY COMPRISING AN INHIBITOR OF BOTH MTORC1 AND MTORC2 | OSI Pharmaceuticals, Inc. (US) | 2010-04-28 | — | — | EP | disclosed |
| WO-2009008992-A2 | COMBINATION ANTI-CANCER THERAPY COMPRISING AN INHIBITOR OF BOTH MTORC1 AND MT0RC2 | OSI PHARMACEUTICALS INC. (US) | 2009-01-15 | — | — | WO | disclosed |
| US-6162804-A | Tyrosine kinase inhibitors | MERCK & CO., INC. (US) | 2000-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10236451-B2 | Compound and organic electroluminescent device comprising the same | VDAC1, PIEZO1, SLCO4C1 | ATM 3553/4885RXFP1 4779/4885NPC1 1690/4885 |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | VDAC1, ALDH2, VDAC2 | ATM 3592/4885RXFP1 4518/4885NPC1 2437/4885 |
| US-20220384735-A1 | PERI-CONDENSED HETEROCYCLIC COMPOUNDS AS MATERIALS FOR ELECTRONIC DEVICES | KCNH1, NES, KCNC1 | ATM 2818/4885RXFP1 4848/4885NPC1 3475/4885 |
| US-20100145054-A1 | IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | TYR, MCHR1, MCHR2 | ATM 1796/4885RXFP1 906/4885NPC1 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.